2071195-74-7 (Epertinib hydrochloride | S-22611 hydrochloride | EGFR,Epertinib hydrochloride)

Epertinib (hydrochloride);(R,Z)-1-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)but-2-yn-1-one O-morpholin-3-ylmethyl oxime hydrochloride;S-22611 hydrochloride;Epertinib hydrochloride;2071195-74-7;(R,Z)-1-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)but-2-yn-1-oneO-morpholin-3-ylmethyloximehydrochloride;N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[(Z)-N-[[(3R)-morpholin-3-yl]methoxy]-C-prop-1-ynylcarbonimidoyl]quinazolin-4-amine;hydrochloride;MS-30577;HY-107367A;AKOS040733113;CS-0092330;

NVWJPQQXBPWOOA-PLXRJBJVSA-N

1S/C30H27ClFN5O3.ClH/c1-2-4-27(37-40-18-24-17-38-12-11-33-24)21-7-9-28-25(14-21)30(35-19-34-28)36-23-8-10-29(26(31)15-23)39-16-20-5-3-6-22(32)13-20;/h3,5-10,13-15,19,24,33H,11-12,16-18H2,1H3,(H,34,35,36);1H/b37-27+;/t24-;/m1./s1

ClC1=C(C=CC(=C1)NC1=C2C(C=CC(=C2)/C(/C#CC)=N/OC[C@H]2COCCN2)=NC=N1)OCC1C=CC=C(C=1)F.Cl